Docon Divests 10% Stake in Thyrocare for ₹668 Crore
Docon Technologies sold 53.33 lakh shares of Thyrocare at Rs 1,252 each, reducing stake to 61%.
Docon Technologies sold 53.33 lakh shares of Thyrocare at Rs 1,252 each, reducing stake to 61%.
Thyrocare Technologies reported a strong Q2 FY26, with a 22% revenue growth to Rs 216.5 crore year-on-year.
Siddharth Shah is stepping down as CEO of API Holdings, transitioning to Vice Chairman on Aug 27, 2025.